SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety

NCT07174947 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Hepatobiliary Malignancy
Fluoxetine
Anxiety Disorders
Depression Disorders

Interventions

DRUG: Fluoxetine (drug)
DRUG: Placebo

Sponsor

First Affiliated Hospital of Wenzhou Medical University